• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA) BIOCOR STENTED TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA) BIOCOR STENTED TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number B100-31M
Device Problem Microbial Contamination of Device (2303)
Patient Problem Endocarditis (1834)
Event Date 05/26/2018
Event Type  Injury  
Event Description
On (b)(6) 2018, a biocor mitral valve (size unknown) was implanted.Following the procedure, the patient required a lengthy icu stay, however no information was provided beyond the patient developed an infection and endocarditis which resulted in a poorly functioning mitral prosthesis.On (b)(6) 2018, the valve was explanted and replaced with a 33 mm biocor valve.The patient was reported to be recovering.A request for the explanted valve was made by the local representative however the valve had been sent off to hospital pathology post explant.
 
Manufacturer Narrative
An event of endocarditis was reported.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
On (b)(6) 2017, a mitral valve replacement was performed due to severe mitral valve regurgitation and a 31 mm biocor mitral valve (sn unknown) was implanted.The patient was stable throughout the procedure.The following year the patient developed presumed bacterial endocarditis of the biocor valve which resulted in a poorly functioning mitral prosthesis.On (b)(6) 2018, the valve was explanted and replaced with a 33 mm biocor valve.Closure of the left atrial appendage was performed during the same procedure.Post-procedure, the patient returned to the icu in a satisfactory and stable condition.A request for the explanted valve was made by the local representative however the valve had been sent off to hospital pathology post explant and is not expected to be returned for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOCOR STENTED TISSUE VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA)
rua professor jose vieira de mendonça 1301
engenho nogueira - belo horizonte - mg
belo horizonte 31310 -260
BR  31310-260
MDR Report Key7643459
MDR Text Key112514850
Report Number3001883144-2018-00057
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/10/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberB100-31M
Device Catalogue NumberB100-31M
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 05/31/2018
Initial Date FDA Received06/27/2018
Supplement Dates Manufacturer Received07/12/2018
Supplement Dates FDA Received08/10/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-